CVE-2023-40277 — MEDIUM (6.1)

Vulnerability Description

An issue was discovered in OpenClinic GA 5.247.01. A Reflected Cross-Site Scripting (XSS) vulnerability has been discovered in the login.jsp message parameter.

CVSS Score

6.1

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

REQUIRED

Scope

CHANGED

Confidentiality

LOW

Integrity

LOW

Availability

NONE

Affected Products

Vendor	Product	Versions
Openclinic Ga Project	Openclinic Ga	5.247.01

Related Weaknesses (CWE)

CWE-79

References

https://github.com/BugBountyHunterCVE/CVE-2023-40277/blob/main/CVE-2023-40277_ReExploitThird Party Advisory
https://sourceforge.net/projects/open-clinic/Product
https://github.com/BugBountyHunterCVE/CVE-2023-40277/blob/main/CVE-2023-40277_ReExploitThird Party Advisory
https://sourceforge.net/projects/open-clinic/Product

FAQ

What is CVE-2023-40277?

CVE-2023-40277 is a vulnerability with a CVSS score of 6.1 (MEDIUM). An issue was discovered in OpenClinic GA 5.247.01. A Reflected Cross-Site Scripting (XSS) vulnerability has been discovered in the login.jsp message parameter.

How severe is CVE-2023-40277?

CVE-2023-40277 has been rated MEDIUM with a CVSS base score of 6.1/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2023-40277?

Check the references section above for vendor advisories and patch information. Affected products include: Openclinic Ga Project Openclinic Ga.